(Q34529725)

2 August 2017

title

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years (English)

1 reference

2 August 2017

Antonio C Wolff

12

0 references

Kathrin Strasser-Weippl

9

object named as

Kathrin Strasser-Weippl

1 reference

2 August 2017

17

Judith S Kaur

1 reference

2 August 2017

5

Hyman Muss

1 reference

2 August 2017

2

James N Ingle

1 reference

2 August 2017

13

Eric Winer

1 reference

2 August 2017

Paul E Goss

1

1 reference

2 August 2017

Kathleen I Pritchard

3

1 reference

2 August 2017

Nicholas J Robert

4

1 reference

2 August 2017

Julie Gralow

6

1 reference

2 August 2017

Karen Gelmon

7

1 reference

2 August 2017

Tim Whelan

8

1 reference

2 August 2017

Sheldon Rubin

10

1 reference

2 August 2017

Keren Sturtz

11

1 reference

2 August 2017

Clifford Hudis

14

1 reference

2 August 2017

Alison Stopeck

15

1 reference

2 August 2017

J Thaddeus Beck

16

1 reference

2 August 2017

Kate Whelan

18

1 reference

2 August 2017

Dongsheng Tu

19

1 reference

2 August 2017

Wendy R Parulekar

20

1 reference

2 August 2017

language of work or name

English

0 references

publication date

5 June 2016

1 reference

The New England Journal of Medicine

2 August 2017

published in

1 reference

2 August 2017

volume

375

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

209-219

1 reference

Extended adjuvant endocrine therapy in hormone-receptor positive breast cancer

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024713

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024713

Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024713

Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation

7 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024713

7 July 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024713

Tamoxifen for early breast cancer.

9 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024713

The MOS 36-ltem Short-Form Health Survey (SF-36)

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024713

Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024713

A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024713

Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024713

A menopause-specific quality of life questionnaire: development and psychometric properties.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024713

Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17

27 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27264120

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1056/NEJMOA1604700

1 reference

2 August 2017

1 reference

2 August 2017

1 reference